Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia

@article{Corfas2004Neuregulin1S,
  title={Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia},
  author={Gabriel Corfas and Kristine Roy and Joseph D. Buxbaum},
  journal={Nature Neuroscience},
  year={2004},
  volume={7},
  pages={575-580}
}
Schizophrenia is a devastating psychiatric disease that affects 0.5–1% of the world's adult population. The hypothesis that this disease is a developmental disorder of the nervous system with late onset of its characteristic symptoms has been gaining acceptance in past years. However, the anatomical, cellular and molecular bases of schizophrenia remain unclear. Numerous studies point to alterations in different aspects of brain development as possible causes of schizophrenia, including defects… 
Neuregulin-1 signaling in schizophrenia
TLDR
Recent studies appear to have identified schizophrenia-relevant functions of the two proteins and provide the biological basis of the increased risk with two genes.
Neuregulin 1 and Schizophrenia: Genetics, Gene Expression, and Neurobiology
Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy
TLDR
Searches for future therapeutic options should aim at compensating disturbed functions of oligodendrocytes, astrocyte and microglial cells, by which at least some aspects of the pathophysiology of the very inhomogeneous clinical syndrome of schizophrenia might be explained.
ErbB4 in Laminated Brain Structures: A Neurodevelopmental Approach to Schizophrenia
TLDR
ErbB4 mutation uncovers flaws in brain development that are compatible with a neurodevelopmental model of schizophrenia, and it establishes a comprehensive model to study the basis of the disorder before symptoms are detected in the adult.
Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes
TLDR
The results indicate that enhanced RPTPβ/ζ signaling can contribute to schizophrenia phenotypes, and support both construct and face validity for PTPRZ1-transgenic mice as a model for multiple schizophrenia phenotype.
Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders
TLDR
It is shown that loss of erbB signaling leads to changes in OL number and morphology, reduced myelin thickness, and slower conduction velocity in CNS axons, indicating that defects in white matter can cause alterations in dopaminergic function and behavior relevant to neuropsychiatric disorders.
Schizophrenia: an integrative approach to modelling a complex disorder.
TLDR
Strategies for modelling schizophrenia that involve treating mice that bear mutations in a variety of ways to better model both environmental and genetic factors responsible for this complex mental illness according to a "two-hit hypothesis" are discussed.
[Advances in neurobiological understanding of schizophrenia. Perspectives for new therapeutic concepts].
TLDR
Biochemical findings supporting this show that besides the dopaminergic and serotonergic system, glutamatergic transmission is also disturbed in schizophrenia, and these findings fit very well with the presumed functions of the disposition genes.
Neuregulin-ERBB Signaling in the Nervous System and Neuropsychiatric Diseases
...
...

References

SHOWING 1-10 OF 70 REFERENCES
Neuregulin 1 and susceptibility to schizophrenia.
TLDR
The results of a genomewide scan of schizophrenia families in Iceland show that schizophrenia maps to chromosome 8p, and extensive fine-mapping of the 8p locus and haplotype-association analysis identifies neuregulin 1 (NRG1) as a candidate gene for schizophrenia.
The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia
TLDR
The hypothesis suggests glial cells as the locus of the genes-environment interactions in schizophrenia, with glial asthenia as an important factor for the genetic liability to the disorder, and an increase of prolactin and/or insulin as possible working mechanisms of traditional and atypical neuroleptic treatments.
Molecular and Cellular Evidence for an Oligodendrocyte Abnormality in Schizophrenia
TLDR
Data demonstrating consistently fewer oligodendrocytes in schizophrenics compared to controls point to a major involvement of oligodendedrocyte abnormalities in schizophrenia, and therapies modulating oligodends survival and differentiation may therefore be beneficial in schizophrenia.
The neuropathology of schizophrenia. A critical review of the data and their interpretation.
TLDR
Functional imaging data indicate that the pathophysiology of schizophrenia reflects aberrant activity in, and integration of, the components of distributed circuits involving the prefrontal cortex, hippocampus and certain subcortical structures.
Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia
TLDR
There was no effect on the NRG-1 mRNA levels of genotype at two SNPs previously associated with schizophrenia, suggesting that these alleles are not functionally responsible for abnormal NRg-1 expression patterns in patients.
Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia
TLDR
It is concluded that widespread abnormalities of thalamic nicotine are not implicated in schizophrenia or DLB, but that reticular αBGT binding may be involved to a lesser and greater extent in the pathophysiology or psychopathology of both disorders.
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia
TLDR
DNA microarray analysis was used to assay gene expression levels in postmortem dorsolateral prefrontal cortex of schizophrenic and control patients, and differential expression of myelination-related genes suggesting a disruption in oligodendrocyte function in schizophrenia were identified.
Recent advances in defining the neuropathology of schizophrenia
TLDR
Six broad areas of neuropathological investigation into schizophrenia are summarized and discussed and a general lack of neurodegenerative disease lesions or ongoing astrocytosis that would indicate post-maturational neural injury is found.
...
...